An Outcome Scale for Pathological Gambling

Award Information
Agency:
Department of Health and Human Services
Branch
n/a
Amount:
$812,980.00
Award Year:
2005
Program:
SBIR
Phase:
Phase II
Contract:
9R44DA020166-02A1
Award Id:
54609
Agency Tracking Number:
1R43MH063515-01
Solicitation Year:
n/a
Solicitation Topic Code:
n/a
Solicitation Number:
n/a
Small Business Information
Psych Products Press, Box 228, East Greenwich, RI, 02818
Hubzone Owned:
N
Minority Owned:
N
Woman Owned:
N
Duns:
n/a
Principal Investigator:
ROBERTBREEN
(401) 277-0707
RBREEN@LIFESPAN.ORG
Business Contact:
MARKZIMMERMAN
(401) 885-6746
MZIMMERMAN@LIFESPAN.ORG
Research Institute:
n/a
Abstract
DESCRIPTION (provided by applicant): Pathological gambling (PG) is a serious public health problem affecting at least 1% of the adult population in the U.S. By extension, it impacts families, business; and communities. Publicly funded-mental health services for pathological gamblers (PGs) exist in some states, but not in others. As the dependence of state governments on gambling revenues increases, public funding for services to PGs should also increase. Instruments that measure the severity of PG have been limited in theoretical frame and content. They tend to assess PG by gambling behavior, debts, and other obvious, immediate consequences. This Phase II application intends to use the Rhode Island Gambling Outcome Rating Scale (RIGORS) in a state-funded, hospital- based gambling treatment program to: 1) Examine the utility of the RIGORS in identifying vulnerability to relapse in PGs during a12-month period. We expect that the RIGORS will provide incremental improvement in predictive validity of outcomes, including point-prevalence abstinence, frequency of gambling, and time to relapse when compared to other commonly used outcome measures; and 2) Establish that the RIGORS has strong, unbiased and stable psychometric properties in evaluating outcomes over time. We will compare the reliability, representativeness of items, levels of discrimination, and influence of gender bias on the RIGORS relative to other methods of assessing the severity of PG over time. 3) Commercially, the RIGORS will fill a niche for a brief, clinically useful, valid and reliable measure of a broad, latent continuum of PG severity. It can be used to monitor treatment effectiveness and cost efficiency, as well as for treatment planning and guidance. We hope to show that the RIGORS will be sensitive and unbiased at lower levels of severity in gamblers, and: thus may be used as a prophylactic tool to signal vulnerability to PG. The target market for the RIGORS will include mental health providers and state agencies that administer services for PG.

* information listed above is at the time of submission.

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government